Venrock is a venture capital firm that partners with entrepreneurs to build leading technology and healthcare companies.

Laurance Rockefeller

Venrock

Medical Devices Venture is a holding company that develops a portfolio of investments in Med Tech start-ups. The aim is to combine the expertise of researchers in hospital and university settings with industrialization and commercialization capabilities.

Medical Devices Venture

Picus Capital is a venture capital firm that specializes in partnering with tech-driven companies to accelerate their growth and scale their operations. The firm provides not only capital but also strategic guidance and operational support to its portfolio companies.

Picus Capital

Paul Veradittakit is a venture investor who focuses on solving problems with a value-add perspective. He has worked in the venture capital space for more than 5 years, helping startups with negotiations, acquisitions, and operational tasks.

Paul Veradittakit

Venrock partners with entrepreneurs who want to tackle big, hard problems that most think not possible. For more information, please visit www.venrock.com or follow the firm on Twitter at @Venrock.Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world’s most disruptive, successful companies. With a primary focus on technology and healthcare, portfolio companies have included Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Endeca, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel, Millennium Pharma, Nest, SlideShare and Tudou. A complete list of Venrock investments is available at Venrock.com.

Tricida

Zenefits

Misty Robotics

Nest Labs

Imperva

Personal Capital

Intel

Biohaven Pharmaceutical

Bristol-Myers Squibb

Castlight Health

10X Genomics

Amunix

Apple

Ascendis Pharma

Shape Security

Cloudflare

Coherus Biosciences

Constellation Pharmaceuticals

Crunchyroll

CVRx

Doctor On Demand

Dollar Shave Club

Lucid Motors

AVEO Oncology

Shockwave Medical

Metric
Company Name	Venrock	Medical Devices Venture	Picus Capital	Paul Veradittakit
Symbol
MSH ID	COM:VENROCK	COM:MEDICALDEVICESVENTURE	COM:PICUSCAP	COM:VERADITTAKIT
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Healthcare & Health Services	Financial Services & Finance	Financial Services & Finance
Industry	Venture Capital	Medical Devices	Venture Capital	Venture Capital
Country	US	FR	DE	US
Stage				Seed
Employee Count	60		186
Website	venrock.com	medicaldevicesventure.com	picuscap.com	veradittakit.com
LinkedIn	venrock	medical-devices-venture	picus-capital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	6.79K	6.59K	1.37K
Web Traffic Growth	-0.03	-0.22	-0.40
Valuation
Raised Capital			4M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:VENROCK

Venrock

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue